Amount Raised
$16.5 Million
Round Type
Post-IPO Equity
RichmondBiotechnologyHealth CareGeneticsTherapeuticsInvestors
Description
Sangamo Therapeutics, Inc. has entered into an underwriting agreement for an offering of common stock and pre-funded warrants. The offering consists of over 35 million shares of common stock and accompanying warrants. The combined offering price per share is set at approximately $0.4719, aiming to generate essential funds for the company's ongoing projects.
Quick answer
Sangamo Therapeutics raised $16.5 Million in a Post-IPO Equity round, dated February 4, 2026. Investors: Wells Fargo Securities, LLC and Cantor Fitzgerald & Co. Sangamo Therapeutics is based in Richmond, California, United States.
- How much did Sangamo Therapeutics raise?
- Sangamo Therapeutics raised $16.5 Million in a Post-IPO Equity round on February 4, 2026.
- Who invested in Sangamo Therapeutics?
- Wells Fargo Securities, LLC and Cantor Fitzgerald & Co. are named as investors in this round.
- What does Sangamo Therapeutics do?
- Sangamo Therapeutics, Inc. is a genomic medicine company based in California.
- Where is Sangamo Therapeutics based and how big is it?
- Sangamo Therapeutics is based in Richmond, California, United States. Fundz records about 321 employees.
- Who are the decision-makers at Sangamo Therapeutics?
- Fundz holds 1 contact at Sangamo Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as Sangamo Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Aurora Therapeutics raised $16M (Seed) on January 9, 2026.
- Tempest Therapeutics raised $2M on March 20, 2026.
- Surf Therapeutics raised $6M (Seed) on March 17, 2026.
- R1 Therapeutics raised $78M (Series A) on March 17, 2026.
- VST BIO Corporation raised an undisclosed amount (Series A) on March 17, 2026.
- Acurion raised $4.3M (Seed) on March 17, 2026.
Who to call at Sangamo Therapeutics, and when
A new round usually means Sangamo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sangamo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sangamo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sangamo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sangamo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Sangamo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.